47
Views
2
CrossRef citations to date
0
Altmetric
Articles

Exploiting Nicotinic Receptor Mechanisms for the Treatment of Schizophrenia and Depression

&
Pages 159-167 | Published online: 04 May 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Ingrid Bacher, Becky Wu, Douglas R Shytle & Tony P George. (2009) Mecamylamine – a nicotinic acetylcholine receptor antagonist with potential for the treatment of neuropsychiatric disorders. Expert Opinion on Pharmacotherapy 10:16, pages 2709-2721.
Read now

Articles from other publishers (1)

Pedro Merino. 2019. Chemical Biology of Neurodegeneration. Chemical Biology of Neurodegeneration 121 154 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.